194 related articles for article (PubMed ID: 8501149)
1. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms.
Matsuo K; Friedman E; Gejman PV; Fagin JA
J Clin Endocrinol Metab; 1993 Jun; 76(6):1446-51. PubMed ID: 8501149
[TBL] [Abstract][Full Text] [Related]
2. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation.
Spambalg D; Sharifi N; Elisei R; Gross JL; Medeiros-Neto G; Fagin JA
J Clin Endocrinol Metab; 1996 Nov; 81(11):3898-901. PubMed ID: 8923835
[TBL] [Abstract][Full Text] [Related]
3. G protein and thyrotropin receptor mutations in thyroid neoplasia.
Esapa C; Foster S; Johnson S; Jameson JL; Kendall-Taylor P; Harris PE
J Clin Endocrinol Metab; 1997 Feb; 82(2):493-6. PubMed ID: 9024242
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas.
Derwahl M; Hamacher C; Russo D; Broecker M; Manole D; Schatz H; Kopp P; Filetti S
J Clin Endocrinol Metab; 1996 May; 81(5):1898-904. PubMed ID: 8626855
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of the stimulatory G protein alpha-subunit mutations in autonomously functioning thyroid adenomas in Japan.
Tanaka K; Nagayama Y; Takeshita A; Namba H; Yamashita S; Niwa M; Nagataki S
Thyroid; 1996 Jun; 6(3):195-9. PubMed ID: 8837326
[TBL] [Abstract][Full Text] [Related]
6. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous mutations in the gene encoding the alpha-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy.
Miric A; Vechio JD; Levine MA
J Clin Endocrinol Metab; 1993 Jun; 76(6):1560-8. PubMed ID: 8388883
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of toxic thyroid adenomas and nodules: relevance of activating mutations in the TSH-receptor and Gs-alpha gene, the possible role of iodine deficiency and secondary and TSH-independent molecular mechanisms.
Derwahl M; Manole D; Sobke A; Broecker M
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S6-9. PubMed ID: 9867188
[TBL] [Abstract][Full Text] [Related]
9. Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in thyroid neoplasia.
Ringel MD; Saji M; Schwindinger WF; Segev D; Zeiger MA; Levine MA
J Clin Endocrinol Metab; 1998 Feb; 83(2):554-9. PubMed ID: 9467574
[TBL] [Abstract][Full Text] [Related]
10. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in N-bis(2-hydroxypropyl)nitrosamine-induced rat transplantable thyroid carcinoma lines: analysis of the TSH-R, G(alpha)s, ras and p53 genes.
Kitahori Y; Naitoh H; Konishi N; Ohnishi T; Hiasa Y
Carcinogenesis; 1997 Feb; 18(2):265-9. PubMed ID: 9054617
[TBL] [Abstract][Full Text] [Related]
12. TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas--a note of caution.
Derwahl M
J Clin Endocrinol Metab; 1996 Aug; 81(8):2783-5. PubMed ID: 8768829
[TBL] [Abstract][Full Text] [Related]
13. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
Parma J; Duprez L; Van Sande J; Hermans J; Rocmans P; Van Vliet G; Costagliola S; Rodien P; Dumont JE; Vassart G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2695-701. PubMed ID: 9253356
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin receptor: a role for thyroid tumourigenesis?
Russo D; Arturi F; Chiefari E; Filetti S
Forum (Genova); 1999; 9(2):166-75. PubMed ID: 10385711
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil.
Nogueira CR; Kopp P; Arseven OK; Santos CL; Jameson JL; Medeiros-Neto G
Thyroid; 1999 Nov; 9(11):1063-8. PubMed ID: 10595453
[TBL] [Abstract][Full Text] [Related]
16. gsp mutations in human thyroid tumours.
Suarez HG; du Villard JA; Caillou B; Schlumberger M; Parmentier C; Monier R
Oncogene; 1991 Apr; 6(4):677-9. PubMed ID: 1903197
[TBL] [Abstract][Full Text] [Related]
17. Non-hyperfunctioning nodules from multinodular goiters: a minor role in pathogenesis for somatic activating mutations in the TSH-receptor and Gsalpha subunit genes.
Derrien C; Sonnet E; Gicquel I; Le Gall JY; Poirier JY; David V; Maugendre D
J Endocrinol Invest; 2001 May; 24(5):321-5. PubMed ID: 11407651
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations.
Harris PE; Alexander JM; Bikkal HA; Hsu DW; Hedley-Whyte ET; Klibanski A; Jameson JL
J Clin Endocrinol Metab; 1992 Sep; 75(3):918-23. PubMed ID: 1517386
[TBL] [Abstract][Full Text] [Related]
20. Toxic thyroid adenoma: absence of DNA mutations of the TSH receptor and Gs alpha.
Pinducciu C; Borgonovo G; Arezzo A; Torre GC; Giordano G; Cordera R
Eur J Endocrinol; 1998 Jan; 138(1):37-40. PubMed ID: 9461313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
